Short commentary
Hemorrhagic stroke is five times less common than ischemic
stroke, but deaths from it are much more frequent [1-7]. This is
due to the rapid development of cerebral edema and displacement
of the brain tissue by a hematoma (accumulation of blood).
Hemorrhagic stroke is the second most common after ischemic
stroke. The high-risk group (95% of cases) includes smokers over
50 years of age, suffering from chronic inflammatory diseases,
hypertension, overweight and sleep disturbance. Due to constant
changes in blood pressure under conditions of nitrosative and
oxidative stress that occurs in chronic inflammatory diseases, the
vessel wall becomes thinner, and at some point it completely or
partially ruptures [6-8].
A micro stroke is a micro damage and disruption of the brain
as a result of a lack of oxygen. It does not cause significant harm,
but is an indicator of various disorders. At the same time, doctors
often do not call such a disease as a micro stroke. Now they are
increasingly inclined to believe that this is the same stroke only
in a mild form or a transient cerebrovascular accident. Currently,
there is no definitively established opinion on the advantage of
surgical treatment of hemorrhages over their medical treatment
[9,10]. However, in recent years it has come to be considered
that, despite the lack of definitive evidence in favor of surgical
intervention, there is nevertheless a good theoretical rationale
for early surgical intervention. Surgery should be considered
justified in patients with moderate to large hemorrhages in the
lobes or basal ganglia. Surgery is also warranted in patients with progressive neurological deterioration. Elderly patients with a
Glasgow Coma Score less than 5, patients with brainstem bleeds,
and patients with minor bleeds usually do not benefit significantly
from surgery. In patients with cerebellar hemorrhages of more
than 3 cm, with compression of the brainstem and hydrocephalus,
or with neurological disorders due to thrombosis of cerebral
vessels, the thrombus is most often surgically removed [8-10].
Among famous people (VIP) in the 20th century, many political,
state, military and party leaders died of hemorrhagic stroke. In
the past century, eleven (11) Presidents of the United States were
believed to have died of strokes associated with cardiovascular
disease. All three top leaders of the countries - F.D. Roosevelt
(1882-1945), I.W. Stalin (1878/1879-1953.03.05) and W. Churchill
(1874-1965), who took part in the Tehran (1943) and Yalta
conferences (1945) (Figure 1), died from cerebrovascular accident.
All of them smoked a lot, despite the fact that they suffered from
hypertension for a long time. Roosevelt did not live to see Victory
Day - at the age of 63 he developed a cerebral hemorrhage. Stalin
outlived him and died at the age of 74. Churchill lived a long life
(over 90 years), smoked a lot, suffered from obesity. Churchill
had a series of small strokes (micro strokes), which led him to
dementia at the end of his life.
In the 21st century, the number of US presidents who died
of a stroke or coronary artery disease was again calculated. It
turned out that out of fifteen US presidents since 1900 – from
Theodore Roosevelt (1858–1919) to Ronald Reagan (1911–2004)
– thirteen died from this disease. In the 21st century, Ariel Sharon (1928–2014) died of a hemorrhagic stroke [11-14]. He did not
smoke, maintained pressure within the physiological norm, but
suffered from obesity: with a height of 160 cm, in the last years
of his life, his body weight was from 110 to 118 kg. After the first
micro stroke on December 17/18, 2005, he returned to work 2
days later. However, on January 4, 2006, a second massive stroke
occurred, which required surgical intervention [11,12]. On January 4, 2006, he fell into a coma, in which he remained until his
death on January 11, 2014.
In the 21st century, the attention of local and international
media (media) has been focused on neurosurgeons. In the public
debate that followed, it was suggested that the emergency measures (surgical treatment) were taken only because of the fame of
the patient. However, there were also contrary statements that
it is very difficult to make a decision on the surgical treatment of
famous people (VIP). The provision of emergency care to a major
government official requires the medical staff to resolve many administrative issues [12,13]. Why can even local hemorrhages in
low-intensity strokes lead to catastrophic consequences?
We have obtained data indicating that blood serum albumin
under conditions of excess glutamate (Glu) and activation of nitric
oxide/nitric dioxide (NO/NO2) synthesis can lead to further death
of nerve cells by the necrosis mechanism [14]. These data may
indicate that there is no non-life-threatening local cerebral hemorrhage. This becomes especially important when the formation
of reactive forms of nitrogen and oxygen is activated, when there
is an opportunity for the formation of nitric dioxide (•NO2), •OH-radicals, and peroxynitrites, which can again turn into highly reactive •NO2 and •OH-radicals [15]. These highly reactive radicals
oxidize unsaturated fatty acids that are part of membrane lipids.
After that, the membranes of nerve cells begin to be actively damaged as a result of the binding of oxidized unsaturated fatty acids
by blood serum albumin.
Declarations
Conflicts of interest: The authors declare no conflict of interest.
All authors have read and agreed to the published version of
the manuscript.
Funding: This work was supported by Russian Academy of Sciences and Ministry of Health of the Russian Federation.
References
- Jadhav AP, Desai SM, Liebeskind DS, Wechsler LR. Neuroimaging of
Acute Stroke. Neurol Clin. 2020; 38: 185-199.
- Hoye AT, Davoren JE, Wipf P, Fink MP, Kagan VE. Targeting mitochondria. Acc Chem Res. 2008; 41: 87-97.
- Jiang Y, Liu Z, Liao Y, Sun S, Dai Y, et al. Ischemic stroke: From pathological mechanisms to neuroprotective strategies. Front Neurol.
2022; 13: 1013083.
- Mao R, Zong N, Hu Y, Chen Y, Xu Y. Neuronal Death Mechanisms
and Therapeutic Strategy in Ischemic Stroke. Neurosci Bull. 2022; 38: 1229-1247.
- Zhang Q, Jia M, Wang Y, Wang Q, Wu J. Cell Death Mechanisms in
Cerebral Ischemia-Reperfusion Injury. Neurochem Res. 2022; 47: 3525-3542.
- Orellana-Urzúa S, Rojas I, Líbano L, Rodrigo R. Pathophysiology of
Ischemic Stroke: Role of Oxidative Stress. Curr Pharm Des. 2020; 26: 4246-4260.
- Kamalian S, Lev MH. Stroke Imaging. Radiol Clin North Am. 2019; 57: 717-732.
- Hoffman H, Jalal MS, Chin LS. Prediction of mortality after evacuation of supratentorial intracerebral hemorrhage using NSQIP data.
J Clin Neurosci. 2020; 77: 148-156.
- de Oliveira Manoel AL. Surgery for spontaneous intracerebral
hemorrhage. Crit Care. 2020; 24. 45.
- Blachar Y, Borow M. The health of leaders: information, interpretation and the media. Isr Med Assoc J. 2006; 8: 741-743.
- Naparstek Y. Ariel Sharon’s illness: should we dedicate a medical
journal issue to a single case study? Isr Med Assoc J. 2006; 8: 739-740
- Weiss YG, Mor-Yosef S, Sprung CL, Weissman C, Weiss Y. Caring for
a major government official: challenges and lessons learned. Crit
Care Med. 2007; 35: 1769-1772.
- Dubler NN, Kalkut GE. Caring for VIPs in the hospital: the ethical
thicket. Isr Med Assoc J. 2006; 8: 746-750.
- Sorokina EG, Reutov VP, Pinelis VG. The mechanism of the potentiating action of albumin in the toxic effects of glutamate: the possible role of nitric oxide. Biological membranes. 1999; 16: 318-323.
- Reutov VP, Samosudova NV, Sorokina EG. A model of glutamate
neurotoxicity and mechanisms of the development of the typical
pathological process. Biophysics. 2019; 64: 233-250.